UBS O'Connor’s Corazon Capital V838 Monoceros Corp Class A Ordinary Shares CRZN Stock Holding History

UBS O'Connor’s Portfolio CRZN Stock Details CRZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-236,311	Closed	-$2.39M	–	799
2022 Q4	$2.39M	Sell	236,311 -2,312	-1%	-$23.1K	0.04%	386
2022 Q3	$2.37M	Sell	238,623 -23,888	-9%	-$235K	0.03%	544
2022 Q2	$2.57M	Hold	262,511	–	–	0.03%	545
2022 Q1	$2.56M	Buy	262,511 +4,626	+2%	+$45K	0.03%	510
2021 Q4	$2.52M	Buy	257,885 +6,906	+3%	+$67.2K	0.02%	491
2021 Q3	$2.44M	Hold	250,979	–	–	0.02%	488
2021 Q2	$2.43M	Buy	+250,979	New	+$2.44M	0.02%	443

Other funds holding CRZN

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

UBS O'Connor's CRZN Position: Q1 2023 in Review

UBS O'Connor sold out of Corazon Capital V838 Monoceros Corp Class A Ordinary Shares (CRZN) in Q1 2023, closing a stake of 236,311 shares — an estimated $2.39M sold.

UBS O'Connor first reported a position in CRZN in Q2 2021 and held it in 7 quarters. The position peaked at $2.57M in Q2 2022. 1 fund tracked by Wall St. Rank holds CRZN as of Q1 2023.

UBS O'Connor reported no remaining Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
UBS O'Connor sold 236,311 Corazon Capital V838 Monoceros Corp Class A Ordinary Shares shares in Q1 2023, an estimated $2.39M.
UBS O'Connor first reported a position in Corazon Capital V838 Monoceros Corp Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
UBS O'Connor's Corazon Capital V838 Monoceros Corp Class A Ordinary Shares position peaked at $2.57M in Q2 2022.
1 fund tracked by Wall St. Rank held Corazon Capital V838 Monoceros Corp Class A Ordinary Shares as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.